Mapping the Industry-Funded CME Ecosystem: Treatment Concentration, Structural Redundancy, and the Variable Meaning...

Industry-funded continuing medical education (CME) operates as a global ecosystem spanning multiple accreditation systems, organisational models, and geographic markets. Whether this ecosystem achieves genuine educational independence - and whether existing accreditation mechanisms are capable of ensuring it - are questions the field has not systematically examined at scale. This analysis addresses that gap through three interconnected pillars. The first examines funding concentration using ACCME annual data (2019 to 2024), documenting that publishing and education companies receive a disproportionate share of industry support while the provider pool has grown 52% and per-provider funding has contracted. The second examines content focus through a catalogue audit of more than 1,100 activities across three accreditation frameworks (ACCME-accredited, EBAC/EACCME-accredited, and non-accredited), classifying each by educational focus and documenting content replication patterns. The third examines the variable meaning of independence through comparative analysis of primary source documents from ACCME, EBAC, EACCME, and IACPDA across five dimensions including enforcement and compliance measurement. Findings were consistent across pillars. Treatment-selection content represented 75 to 79% of catalogued activities regardless of framework, speciality, or geography. Diagnostic content concentrated in rare disease indications across all categories. The framework comparison revealed significant asymmetry: ACCME operates five enforceable standards with formal complaint and adverse action mechanisms. Among the public materials reviewed, EBAC maintains a provider appeals process but no documented third-party complaint mechanism; EACCME's publicly available enforcement framework consists of random spot checks. EACCME has not endorsed the 2024 IACPDA Standards for Substantive Equivalency, which require complaint processes and compliance measurement. Content concentration is not a US regulatory artefact but a structural consequence of the grant-funding model, replicating regardless of accreditation framework. Activity-level compliance and ecosystem-level independence are not equivalent. Quality-driven CPD leadership requires portfolio-level visibility, aggregate funding transparency in European accreditation systems, and funder responsibilities to diversify grant portfolios across the full clinical landscape.